Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
or tirzepatide, the active ingredient in Zepbound, White notes
Key findings relevant to injection site safety: Injection site reactions were not significantly higher in retatrutide groups compared to placebo The most common injection site reactions were transient redness and mild discomfort No participants discontinued due to injection site reactions The overall safety profile was consistent with other GLP-1 receptor agonists The more recent TRIUMPH-4 phase 3 trial confirmed these safety findings in a larger population
Someone with a needle phobia or who isnt confident in their ability to self-administer an injection, for example, will probably take the pill more consistently
Direct-to-consumer telehealth companies have grown rapidly in response to patients demand for GLP-1s like semaglutide and tirzepatide, especially after shortages created a market for compounded versions that arent approved by the Food and Drug Administration
US$ 28.38
US$ 28.84
US$ 25.01
US$ 22.07
